Status:

COMPLETED

Transcutaneous Electrical Nerve Stimulation for the Treatment of Premature Ejaculation

Lead Sponsor:

Cairo University

Collaborating Sponsors:

Department of Andrology & STDs Kasr AlAiny Cairo University

Conditions:

Transcutaneous Electrical Nerve Stimulation

Premature Ejaculation

Eligibility:

MALE

20-65 years

Phase:

NA

Brief Summary

Premature ejaculation (PE) is the most prevalent male sexual dysfunction. The currently approved treatments are intolerable to patients due to their side effects. the investigatorsconducted a blinded...

Detailed Description

Trial design A single blinded randomized controlled trial was used, and the ratio of allocation was 1:1. Between 2022 and 2023, this study was conducted on (50) male patients attending the outpatient...

Eligibility Criteria

Inclusion

  • married males
  • with stable and continuous marital relationships
  • diagnosed with premature ejaculation based on the International Society for Sexual Medicine (ISSM-International Society for Sexual Medicine) : (a) within the 1-2 minutes after penetration, the ejaculation always or almost always starts; (b)in all or almost all penetrations, the patient cannot delay the ejaculation; (c) PE generate negative consequences on the patients, such as discomfort, frustration, stress, and/or sexual intimacy avoidance
  • and the patient did not take the treatment for PE in the previous 14 days

Exclusion

  • Patients were excluded if they had erectile dysfunction (measured by the International Index of Erectile function-ILEF-5 questionnaire),
  • inhibited male orgasm
  • reduced sexual desire
  • uncontrolled physical illness
  • active genitourinary tract infection (confirmed by two glasses of urine according to Modified Meares-Stamey technique)
  • mental disorders affecting ejaculatory function such as anxiety, depression, and schizophrenia, history of alcohol or drug abuse

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 9 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06570512

Start Date

January 1 2022

End Date

December 9 2023

Last Update

October 26 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Cairo University

Cairo, Giza Governorate, Egypt

2

Faculty Of Medicine, Cairo University

Cairo, Egypt, 35744